Glabellar Frown Lines (GL)

Glabellar Frown Lines (GL) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Glabellar Frown Lines · Glabellar Lines
Classified under: Physiological and Biological Processes
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Botulinum toxin type A

Resolves to

Vocabularies

SNOMED CT247434009MedDRA10040954UMLSC0037301

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

129Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Glabellar Frown Lines (GL) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.